Navigation Links
SARcode Bioscience Announces Acquisition by Shire US Holdings Inc.
Date:3/25/2013

ed in both corneal and conjunctival staining, key indicators of ocular surface health.  Lifitegrast also improved eye dryness and ocular discomfort, the two most commonly reported symptoms of dry eye. Lifitegrast was well tolerated and there were no unexpected or serious ocular adverse events. The most commonly reported ocular adverse events were initial instillation site complaints, and were generally mild and transient in nature.

About Dry Eye Disease

Dry eye disease is a prevalent and often chronic condition estimated to affect approximately 25 million people in the US and 370 million people worldwide. This number is expected to grow substantially in the next decade due to an aging population and increasing incidence of type-2 diabetes, both of which contribute to higher rates of this condition.  Dry eye disease is among the most common disorders treated by ophthalmologists throughout the world.  Dry eye varies in severity and etiology, and symptoms most commonly manifest as ocular discomfort, eye dryness, and tear film instability due to decreased quality or quantity of tears.  A major contributing factor towards the development of dry eye is inflammation caused by T-cell infiltration, proliferation and inflammatory cytokine production that can lead to reduction in tear film quality and ocular surface damage.

About SARcode Bioscience

SARcode Bioscience, Inc., founded in 2006, is an ophthalmic biopharmaceutical company based in Brisbane, CA.  SARcode's lead development program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. www.sarcode.com


'/>"/>
SOURCE SARcode Bioscience, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Industry Veteran Katrine Bosley Joins Genocea Biosciences Board Of Directors
2. Pressure BioSciences, Inc. to Present at the SeeThruEquity Spring Investor Microcap Forum
3. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
4. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
5. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
6. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
7. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
8. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
9. Dr. Mickey Urdea Joins Pressure BioSciences Board of Directors
10. Dr. Susan Froshauer to join Connecticut bioscience team at CURE
11. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , Oct. 20, 2014  ResMed (NYSE: ... of the ResMed Data Exchange program, a comprehensive ... medical equipment (HME) and other health care providers. ... secure access to critical patient information. It integrates ... AirView™ and U-Sleep™ patient management platforms with customers, ...
(Date:10/20/2014)...  AnaptysBio, Inc., a leader in the discovery ... appointment of Marco Londei , M.D. as ... preclinical and clinical development of AnaptysBio,s proprietary antibody ... welcome Dr. Londei to AnaptysBio,s executive leadership team," ... Executive Officer of AnaptysBio. "Dr. Londei,s extensive expertise ...
(Date:10/20/2014)... 20, 2014 Pharmaceutic Labs announces the opening ... Albany, NY for admixing, compounding, drug ... and/or exceeds the FDA standards for safety and quality, ... 211. The 10,000 square foot outsourcing ... quality assurance and quality control. The company will produce ...
Breaking Medicine Technology:ResMed Launches ResMed Data Exchange 2AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2
... N.J., Jan. 6, 2012 Savient Pharmaceuticals, Inc. (NASDAQ: ... code, or permanent J-code, for KRYSTEXXA® (pegloticase) became available ... assigned by the Centers for Medicare and Medicaid Services ... process for prescribers of KRYSTEXXA, the first and only ...
... 6, 2012 Biodel Inc. (Nasdaq: BIOD ) ... of Biodel, will present a corporate update at the 30th ... 1:00 p.m. Pacific Time (4:00 p.m. Eastern Time). ... 2012, at the Westin St. Francis Hotel in San Francisco, ...
Cached Medicine Technology:Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA® 2Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA® 3Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA® 4Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA® 5Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA® 6
(Date:10/20/2014)... T.E.N., a technology and information security ... William H. Murray, renowned author and industry visionary, ... Award winner. Presented annually, the ISE® Luminary Leadership ... and industry practitioner for his or her distinguished ... security industry. , Formerly with IBM, Murray is ...
(Date:10/20/2014)... Principle Business Enterprises, a family owned company ... absorbent products. The company has recently made efforts ... Tranquility® Premium Protection absorbent products. The company has ... packaging a new look, and is currently working on ... public. , The new website, developed with Thread Marketing ...
(Date:10/20/2014)... 20, 2014 Based on a ... only imaging assays capable of determining DNA sequence, ... With these three dimensions of high-resolution data, dGH ... the widest range of disease-causing genetic rearrangements, including ... other genomic tools, including today’s advanced sequencing technologies. ...
(Date:10/20/2014)... 2014 Punzoné , the first line ... has a lot to celebrate this month. October marks Italian ... achievements and contributions of Americans of Italian heritage and Italians ... today it shares its favorite Italian cocktails and encourages everyone ... - even if it is only in a glass. ...
(Date:10/19/2014)... BambooIndustry.com, one of the most popular suppliers of bamboo ... deckings . Moreover, the company has launched a special ... at deeply discounted rates. , As is known ... significance of online business nowadays. Thus, BambooIndustry.com pays a ... are striving to deliver both value and efficiency for ...
Breaking Medicine News(10 mins):Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2
... 2008) The Virginia Commonwealth University School of Medicine ... from the National Institutes of Healths National Institute on ... syndrome, a disorder of the endocrine system that affects ... syndrome, or PCOS, causes hormonal imbalances leading to irregular ...
... LAKE CITY, May 12 Dynatronics,Corporation (Nasdaq: ... quarter,ended March 31, 2008 on Wednesday, May 14, ... for investors later that,day at 2:30 p.m. ET ... nine month,periods. Those interested in participating should call ...
... to expand oral health care services; awards two significant oral health ... ... As part of the Illinois,Children,s Healthcare Foundation,s (ILCHF) $20 million, five-year,initiative to ... to announce a request for proposals in the oral,health care field. The ...
... http://www.cryocath.com Toronto Stock Exchange Symbol: CYT, MONTREAL, ... in cryotherapy products to treat cardiac,arrhythmias, today announced financial ... Selected Second Quarter Financial and Operational Highlights:, ... to $10.2 million or a 37.6% ...
... MELVILLE, N.Y., May 12 Gentiva Health,Services, Inc. (Nasdaq: ... health services, announced today that it is scheduled to,present ... 21, 2008 at the 2008,Citi Investment Research Global Health ... be available to the public via a live audio ...
... Low IQ more likely the younger a child is at diagnosis, ... about 5 percent of people with multiple sclerosis are diagnosed when ... cognitive function, causing memory and attention problems, and possibly low IQ ... time of diagnosis, the more likely he or she is to ...
Cached Medicine News:Health News:NIH grant to support Translational Research Center for PCOS 2Health News:Children in Illinois to Have Healthier Smiles 2Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 2Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 3Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 4Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 5Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 6Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 7Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 8Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 9Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 10Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 11Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 12Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 2Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 3Health News:Multiple Sclerosis Affects Children's Cognitive Skills 2Health News:Multiple Sclerosis Affects Children's Cognitive Skills 3
Schlesinger Laminectomie Rongeur, golden springs. 15 cm - 6, with narrow footplate, large handle, 40 down-cutting, jaws 3 mm wide....
... The Tangent Posterior Impacted Instrument Set offers ... of the advantages offered by the Tangent ... preparation and the ability to reproduce the ... to ensure proper vertebral body distraction. A ...
Codman Hakim Programmable micro with Rickham Reservoir offers the ability to optimize the opening pressure of a shunt system before and after implantation. A shunted patient's condition will often ch...
... Osteopal V is a low viscosity ... use in vertebroplasty. The bone cement is ... stabilization purposes. Osteopal V is used for ... concentration of zirconium dioxide is included in ...
Medicine Products: